NAPROXEN AND ESOMEPRAZOLE MAGNESIUM

NAPROXEN AND ESOMEPRAZOLE MAGNESIUM was reported 13 times

NAPROXEN AND ESOMEPRAZOLE MAGNESIUM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CONNECTIVE TISSUE DISEASE-ASSOCIATED INTERSTITIAL LUNG DISEASE 1 0.0182
1 ATRIAL ENLARGEMENT 1 0.0037
2 BLADDER MASS 1 0.0020
3 NEUROLOGIC NEGLECT SYNDROME 1 0.0018
4 TENOSYNOVITIS STENOSANS 1 0.0018
5 VEIN COLLAPSE 1 0.0013
6 CAROTID ARTERY THROMBOSIS 1 0.0012
7 SPINAL LAMINECTOMY 1 0.0010
8 POST-ACUTE COVID-19 SYNDROME 1 0.0008
9 ADJUSTMENT DISORDER 1 0.0008
10 CARDIAC FIBRILLATION 1 0.0007
11 SCLERITIS 1 0.0006
12 BLADDER NEOPLASM 1 0.0006
13 INFUSION SITE BRUISING 1 0.0005
14 PERSONALITY DISORDER 1 0.0004
15 RHEUMATOID NODULE 1 0.0004
16 PLEURITIC PAIN 1 0.0004
17 CREPITATIONS 1 0.0003
18 PROSTATOMEGALY 1 0.0003
19 SYNOVIAL CYST 1 0.0002
20 ORGANISING PNEUMONIA 1 0.0002
21 APLASTIC ANAEMIA 1 0.0002
22 GANGRENE 1 0.0002
23 PLATELET COUNT ABNORMAL 1 0.0002
24 BRONCHIECTASIS 1 0.0001
25 ARTERIAL OCCLUSIVE DISEASE 1 0.0001
26 ATRIAL FLUTTER 1 0.0001
27 SENSORY LOSS 1 0.0001
28 HEMIPLEGIA 1 0.0001
29 SEDATION 3 0.0001
30 FLANK PAIN 1 0.0001
31 AFFECT LABILITY 1 0.0001
32 HYPERCHOLESTEROLAEMIA 1 0.0001
33 ATELECTASIS 1 0.0001
34 MOTOR DYSFUNCTION 1 0.0001
35 POOR VENOUS ACCESS 1 0.0001
36 TENDERNESS 1 0.0001
37 NIGHTMARE 3 0.0001
38 BURSITIS 1 0.0001
39 MUSCLE SPASTICITY 1 0.0001
40 SINUS CONGESTION 1 0.0001
41 COORDINATION ABNORMAL 1 0.0001
42 MYELODYSPLASTIC SYNDROME 1 0.0001
43 SKIN HAEMORRHAGE 1 0.0001
44 COLON CANCER 1 0.0001
45 RESPIRATORY TRACT CONGESTION 1 0.0001
46 ULCER 1 0.0001
47 HEMIPARESIS 1 0.0001
48 PHOTOPHOBIA 1 0.0001
49 FEELING JITTERY 1 0.0001
50 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
51 SINUS DISORDER 1 0.0001
52 EATING DISORDER 1 0.0000
53 IMPAIRED WORK ABILITY 1 0.0000
54 SNEEZING 1 0.0000
55 PRODUCT AVAILABILITY ISSUE 1 0.0000
56 NEPHROLITHIASIS 2 0.0000
57 ARRHYTHMIA 2 0.0000
58 INTERSTITIAL LUNG DISEASE 2 0.0000
59 ERECTILE DYSFUNCTION 1 0.0000
60 ANGINA PECTORIS 1 0.0000
61 APHASIA 1 0.0000
62 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
63 SWOLLEN TONGUE 1 0.0000
64 CYSTITIS 1 0.0000
65 DYSARTHRIA 1 0.0000
66 HYPERHIDROSIS 3 0.0000
67 GASTROINTESTINAL DISORDER 2 0.0000
68 RENAL DISORDER 1 0.0000
69 OCULAR HYPERAEMIA 1 0.0000
70 EYE PAIN 1 0.0000
71 RHEUMATOID ARTHRITIS 2 0.0000
72 CATARACT 1 0.0000
73 RHINORRHOEA 1 0.0000
74 NEOPLASM MALIGNANT 1 0.0000
75 BLOOD PRESSURE INCREASED 2 0.0000
76 ARTHRITIS 1 0.0000
77 CARDIAC FAILURE CONGESTIVE 1 0.0000
78 INFLUENZA LIKE ILLNESS 1 0.0000
79 PRODUCT USE IN UNAPPROVED INDICATION 3 0.0000
80 SKIN EXFOLIATION 1 0.0000
81 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
82 MUSCULOSKELETAL STIFFNESS 1 0.0000
83 DYSPHAGIA 1 0.0000
84 CHEST DISCOMFORT 1 0.0000
85 SINUSITIS 1 0.0000
86 INFLUENZA 1 0.0000
87 MUSCULAR WEAKNESS 1 0.0000
88 PALPITATIONS 1 0.0000
89 PSORIASIS 1 0.0000
90 COUGH 2 0.0000
91 INFECTION 1 0.0000
92 NAUSEA 5 0.0000
93 CONFUSIONAL STATE 1 0.0000
94 CEREBROVASCULAR ACCIDENT 1 0.0000
95 URINARY TRACT INFECTION 1 0.0000
96 COVID-19 1 0.0000
97 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
98 NASOPHARYNGITIS 1 0.0000
99 ASTHENIA 2 0.0000
100 OFF LABEL USE 4 0.0000
101 VOMITING 2 0.0000
102 ANXIETY 1 0.0000
103 PAIN IN EXTREMITY 1 0.0000
104 PNEUMONIA 1 0.0000
105 FALL 1 0.0000
106 PYREXIA 1 0.0000
107 MALAISE 1 0.0000
108 DYSPNOEA 1 0.0000
109 PAIN 1 0.0000
110 HEADACHE 1 0.0000
111 DIARRHOEA 1 0.0000
112 DRUG INEFFECTIVE 2 0.0000
113 FATIGUE 1 0.0000